ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Regulus Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA for RGLS8429
January 21, 2022Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that the Company... -
Regulus Announces New Additions to Board of Directors
June 12, 2019Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs…… -
Aptuit, Regulus in Strategic Provider Pact
June 13, 2017To provide a range of discovery, CMC and non-clinical services
Pharma Sources Insight January 2025
